Trial Outcomes & Findings for An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring (NCT NCT05674292)

Results Overview

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

25 participants

Primary outcome timeframe

2 weeks

Results posted on

2023-09-13

Participant milestones
Measure	Erchonia Violet Zerona Z6 405nm violet laser light therapy. Erchonia Violet Zerona Z6: 405nm violet diode low level laser device
Overall Study STARTED	25
Overall Study COMPLETED	25
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort
Measure	Erchonia Violet Zerona Z6 n=25 Participants 405nm violet laser light therapy. Erchonia Violet Zerona Z6: 405nm violet diode low level laser device
Age, Categorical <=18 years	0 Participants n=25 Participants
Age, Categorical Between 18 and 65 years	23 Participants n=25 Participants
Age, Categorical >=65 years	2 Participants n=25 Participants
Sex: Female, Male Female	21 Participants n=25 Participants
Sex: Female, Male Male	4 Participants n=25 Participants

Timeframe: 2 weeks

Mean change in total combined circumference inches of the waist, hips and bilateral thighs from baseline to endpoint evaluation.

Outcome measures
Measure	Erchonia Violet Zerona Z6 n=25 Participants 405nm violet laser light therapy. Erchonia Violet Zerona Z6: 405nm violet diode low level laser device
Combined Circumference Reduction in Inches of the Waist, Hips, and Bilateral Thighs	-3.91 inches Standard Deviation 1.649

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Erchonia Corporation

Phone: 8882420571